Dr. Gordon B. Mills earned his M.D. and Ph.D. in biochemistry and completed his training in Obstetrics and Gynecology at the University of Alberta. Prior to moving the Knight Cancer Institute, Dr. Mills was at the MD Anderson Cancer Center, the number one ranked Cancer Center in the United States. He fulfilled multiple roles including founding chair of the Department of Systems Biology, co-Director of the Sheikh Zayed bin Sultan Al Nahyan Institute for Personalized Cancer Therapy co-Director of the Kleberg Center for Molecular Markers and holds the Olga Keith Wiess Distinguished University Chair for Cancer Research at the MD Anderson Cancer Center. At the Knight Cancer Institute at the Oregon Health Sciences University, Dr. Mills is Director of Precision Oncology and SMMART trials. He is responsible for the implementation of an integrated program of tumor analysis, decision-making and implementation of novel precision oncology trials.
1984 University of Alberta, Edmonton, CAN, Ph.D., Biochemistry
1982 University of Alberta, Edmonton, CAN, FRCS, Obstetrics and Gynecology
1977 University of Alberta, Edmonton, CAN, M.D., Medicine
1975 University of Alberta, Edmonton, CAN, B.S., Medicine
Integrative bioinformatics and functional characterization of oncogenic driver aberrations in cancer
Biological annotation of TCGA data
The Role of Aberrant Splicing of EVl1 in Ovarian Cancer Pathophysiology
MMAC1/PTEN Tumor Suppressor and Breast Cancer
CD Signalilng Through EMT/ITK Tyrosine Kinase
U.T. M. D. Anderson Cancer Center Spore in Ovarian Cancer
Putative Tumor Suppressor PTP1C in Breast Cancer
Growth Factor Receptor Signaling in Breast Cancer
7515 Main Street, Suite 195,
Houston, Texas 77030,
Monday to Friday 8am - 6pm
imaware™ provides laboratory testing for wellness monitoring, informational, and educational use.
*Our tests are not intended to diagnose any conditions - only your healthcare provider can make that determination.